Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploring the Psychoactive Effects of Paracetamol
2025-522753-19-02Phase 4Authorised
- Sponsor
- Oslo Metropolitan University
- Start
- Jan 2026
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial comparing Paracetamol Norfri with Placebo (2 arms). Planned start Jan 2026; status: authorised.
02
Drugs
Norfri
Beyond the preview
Go deeper on 2025-522753-19-02.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522753-19-02.